"Onychomycosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.
| Descriptor ID |
D014009
|
| MeSH Number(s) |
C01.539.800.200.720.550 C01.703.295.872.458 C17.800.529.550 C17.800.838.208.883.458
|
| Concept/Terms |
Onychomycosis- Onychomycosis
- Onychomycoses
- Nail Fungus
- Fungus, Nail
- Tinea Unguium
|
Below are MeSH descriptors whose meaning is more general than "Onychomycosis".
Below are MeSH descriptors whose meaning is more specific than "Onychomycosis".
This graph shows the total number of publications written about "Onychomycosis" by people in this website by year, and whether "Onychomycosis" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 1 | 4 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 3 |
Below are the most recent publications written about "Onychomycosis" by people in Profiles.
-
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients. J Drugs Dermatol. 2020 Sep 01; 19(9):867-872.
-
Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events. Dermatol Online J. 2020 Jul 15; 26(7).
-
Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study. J Am Acad Dermatol. 2021 Apr; 84(4):1140-1142.
-
Cross-Linked Fluorescent Supramolecular Nanoparticles for Intradermal Controlled Release of Antifungal Drug-A Therapeutic Approach for Onychomycosis. ACS Nano. 2018 07 24; 12(7):6851-6859.
-
In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis. Antimicrob Agents Chemother. 2018 01; 62(1).
-
Pediatric Onychomycosis: The Emerging Role of Topical Therapy. J Drugs Dermatol. 2017 02 01; 16(2):105-109.
-
Over-the-counter and natural remedies for onychomycosis: do they really work? Cutis. 2016 Nov; 98(5):E16-E25.
-
Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population. Pediatr Dermatol. 2017 Jan; 34(1):46-49.
-
Antifungal ME1111 in vitro human onychopharmacokinetics. Drug Dev Ind Pharm. 2017 Jan; 43(1):22-29.
-
Emerging therapies for the treatment of ungual onychomycosis. Drug Dev Ind Pharm. 2015; 41(10):1575-81.